These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5403411)

  • 1. [Pulmonary fibrosis, a major symptom of scleroderma. Histological data].
    Barrière H; Moigneteau C; de Lajartre
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(2):239-41. PubMed ID: 5403411
    [No Abstract]   [Full Text] [Related]  

  • 2. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-1989. A 33-year-old woman with exertional dyspnea and Raynaud's phenomenon.
    N Engl J Med; 1989 May; 320(20):1333-40. PubMed ID: 2716773
    [No Abstract]   [Full Text] [Related]  

  • 3. The pulmonary manifestations of systemic sclerosis.
    Phillips B; Powell RD; Gammon D; Woodring JH
    J Ky Med Assoc; 1985 Nov; 83(11):611-6. PubMed ID: 4067388
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pulmonary lesions in scleroderma].
    Kukhazh E; Iablon'ska D
    Klin Med (Mosk); 1978 Apr; 56(4):32-7. PubMed ID: 661166
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulmonary changes in progressive systemic sclerosis].
    Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive systemic sclerosis and pulmonary cancer.
    Tesluk H
    Arch Pathol Lab Med; 1984 Jan; 108(1):7-8. PubMed ID: 6546342
    [No Abstract]   [Full Text] [Related]  

  • 7. The spectrum of scleroderma (II).
    LeRoy EC; Lomeo R
    Hosp Pract (Off Ed); 1989 Nov; 24(11):65-8, 69-72, 75-6 passim. PubMed ID: 2509504
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advances in the treatment of scleroderma].
    Marquet R; Vilardell M
    Med Clin (Barc); 1984 Jun; 83(2):74-7. PubMed ID: 6147448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bronchiolo-alveolar carcinoma in the lung with scleroderma].
    Cavazzini L; Bearzi I; Fabris G
    Riv Patol Clin Sper; 1970; 11(2):109-22. PubMed ID: 4334667
    [No Abstract]   [Full Text] [Related]  

  • 10. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma.
    Wusirika R; Ferri C; Marin M; Knight DA; Waldman WJ; Ross P; Magro CM
    Am J Clin Pathol; 2003 Oct; 120(4):596-606. PubMed ID: 14560571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma of lung without significant complications.
    Holden M
    N Y State J Med; 1970 Oct; 70(20):2599-602. PubMed ID: 5272945
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of leukotrienes in alveolitis associated with scleroderma.
    Simms RW; Korn JH
    Arthritis Rheum; 2003 Jun; 48(6):1478-80. PubMed ID: 12794812
    [No Abstract]   [Full Text] [Related]  

  • 13. Educational case report - self assessment.
    Walker T
    Cytopathology; 2002 Oct; 13(5):329. PubMed ID: 12421450
    [No Abstract]   [Full Text] [Related]  

  • 14. Scleroderma lung disease: evolving understanding in light of newer studies.
    Antoniou KM; Wells AU
    Curr Opin Rheumatol; 2008 Nov; 20(6):686-91. PubMed ID: 18946329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma.
    Jacobs S
    J La State Med Soc; 1975 Apr; 127(4):137, 139-43. PubMed ID: 1127301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinicofunctional aspects of the pulmonary complications of scleroderma].
    Rancea D; Nicoară O; Coman N
    Ftiziologia; 1973; 22(1):45-8. PubMed ID: 4690195
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiphospholipid antibodies and systemic scleroderma. Apropos of a case with review of the literature].
    Marrakchi H; Fazaa B; Gorgi Y; Jellouli A; Mokhtar I; Kamoun MR
    Tunis Med; 1995 Feb; 73(2):149-52. PubMed ID: 9506158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Retroperitoneal fibrosis and generalized scleroderma].
    Cochat P; Colon S; Laville M; Maillet P; Lefrançois N; Moskovtchenko JF; Traeger J
    Nephrologie; 1985; 6(1):27-30. PubMed ID: 4000379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial lung disease in scleroderma.
    White B
    Rheum Dis Clin North Am; 2003 May; 29(2):371-90. PubMed ID: 12841300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.
    Thachil J
    Med Hypotheses; 2009 Mar; 72(3):291-3. PubMed ID: 19036527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.